Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoma, Hepatocellular × balstilimab × 90 days × Clear all

Sponsor

Conditions

Colorectal Neoplasms 5 Neoplasm Metastasis 2 Stomach Neoplasms 1 Sarcoma 1 Resectable MMR-deficient Solid Tumors 1 Refractory Metastatic Microsatellite Stable Colorectal Cancer (MSS-CRC) 1 Rectal Neoplasms 1 Pancreatic Cancer Metastatic 1 Oropharyngeal Neoplasms 1 Glioma 1 Diffuse Intrinsic Pontine Glioma 1 Colorectal Cancer Metastatic 1 Advanced Renal Cell Carcinoma 1

Interventions

Bevacizumab 24 atezolizumab 19 durvalumab 18 Specimen Handling 15 pembrolizumab 12 lenvatinib 11 Magnetic Resonance Spectroscopy 11 tremelimumab 10 Nivolumab 10 Sorafenib 8 Radiosurgery 8 Cyclophosphamide 6 camrelizumab 5 apatinib 5 Ipilimumab 5 tislelizumab 4 regorafenib 4 fludarabine 4 cabozantinib 4 X-Rays 4 Immunoglobulin G 4 sintilimab 3 gadolinium ethoxybenzyl DTPA 3 Immune Checkpoint Inhibitors 3 Ethiodized Oil 3 E-7386 3 Disulfides 3 Blood Specimen Collection 3 Biopsy 3 gadobutrol 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡